Skip to main content
Current Alzheimer Research publishes peer-reviewed frontier review and research articles on all areas of Alzheimer's disease. This multidisciplinary journal will help in understanding the neurobiology, genetics, pathogenesis, and treatment strategies of Alzheimer's disease. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, molecular, and animal models. The journal also covers original articles on recent research in fast emerging areas of molecular diagnostics, brain imaging, drug development and discovery, and clinical aspects of Alzheimer's disease. Manuscripts are encouraged that relate to the synergistic mechanism of Alzheimer's disease with other dementia and neurodegenerative disorders. Book reviews, meeting reports and letters-to-the-editor are also published. The journal is essential reading for researchers, educators and physicians with interest in age-related dementia and Alzheimer's disease. Current Alzheimer Research provides a comprehensive 'bird's-eye view' of the current state of Alzheimer's research for neuroscientists, clinicians, health science planners, granting, caregivers and families of this devastating disease.

Publisher: Bentham Science Publishers

More about this publication?
Volume 8, Number 4, 2011

Articles

Favourites:
ADD

Asymptomatic Alzheimer's Disease: A Prodrome or a State of Resilience?
pp. 330-335(6)
Authors: Driscoll, I.; Troncoso, J.

Favourites:
ADD

Cognition and Neuropathology in Aging: Multidimensional Perspectives from the Rush Religious Orders Study and Rush Memory and Aging Project
pp. 336-340(5)
Authors: Negash, S.; A. Bennett, D.; S. Wilson, R.; A. Schneider, J.; E. Arnold, S.

Favourites:
ADD
Favourites:
ADD

Alzheimer's Disease and Intelligence
pp. 345-353(9)
Authors: A. Yeo, R.; Arden, R.; E. Jung, R.

Favourites:
ADD

Cognitive Reserve in Aging
pp. 354-360(7)
Authors: M. Tucker, A.; Stern, Y.

Favourites:
ADD

Dementia and the Default Mode
pp. 361-365(5)
Author: L. Beason-Held, L.

Favourites:
ADD

In Vivo Human Amyloid Imaging
pp. 366-372(7)
Authors: Sojkova, J.; M. Resnick, S.

Favourites:
ADD

Errors in ADAS-Cog Administration and Scoring May Undermine Clinical Trials Results
pp. 373-376(4)
Authors: Schafer, K.; De Santi, S.; S. Schneider, L.

Favourites:
ADD

Impaired Neural Transmission and Synaptic Plasticity in Superior Cervical Ganglia from β-Amyloid Rat Model of Alzheimer's Disease
pp. 377-384(8)
Authors: H. Alzoubi, K.; A. Alhaider, I.; T. Tran, T.; Mosely, A.; A. Alkadhi, K.

Favourites:
ADD

Tolfenamic Acid Interrupts the De Novo Synthesis of the β-Amyloid Precursor Protein and Lowers Amyloid Beta Via a Transcriptional Pathway
pp. 385-392(8)
Authors: I. Adwan, L.; Basha, R.; Abdelrahim, M.; M. Subaiea, G.; H. Zawia, N.

Favourites:
ADD

Mitochondria as a Therapeutic Target for Aging and Neurodegenerative Diseases
pp. 393-409(17)
Authors: H. Reddy, P.; P. Reddy, T.

Favourites:
ADD

How Should We Deal with Missing Data in Clinical Trials Involving Alzheimer's Disease Patients?
pp. 421-433(13)
Authors: Coley, N.; Gardette, V.; Cantet, C.; Gillette-Guyonnet, S.; Nourhashemi, F.; Vellas, B.; Andrieu, S.

Favourites:
ADD
Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content